Biologics: Targets and Therapy, Volume 3, Issue (2009)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Biologics: Targets and Therapy, Volume 3, Issue (2009)

See all volumes and issues
Vol 18, 2024 Vol 17, 2023 Vol 16, 2022 Vol 15, 2021 Vol 14, 2020 Vol 13, 2019 Vol 12, 2018 Vol 11, 2017 Vol 10, 2016 Vol 9, 2015 Vol 8, 2014 Vol 7, 2013 Vol 6, 2012 Vol 5, 2011 Vol 4, 2010 Volume 3, 2009 Vol 2, 2008 Vol 1, 2007
Download citations Download PDFs

Review

Review Article
Botulinum toxin type A in the treatment of patients with cervical dystonia
Allison Brashear
Pages: 1-7
Published online: 07 Dec 2022
AbstractforBotulinum toxin type A in the treatment of patients with cervical dystonia | Full Text | References | PDF (91.9 KB)
  • 90 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer
Bernadette Biondi, Melania Pulcrano, Loredana Pagano & Gaetano Lombardi
Pages: 9-13
Published online: 07 Dec 2022
AbstractforAdjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer | Full Text | References | PDF (72.1 KB)
  • 54 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Current available therapies and future directions in the treatment of malignant gliomas
Annick Desjardins, David A Reardon & James J Vredenburgh
Pages: 15-25
Published online: 07 Dec 2022
AbstractforCurrent available therapies and future directions in the treatment of malignant gliomas | Full Text | References | PDF (101.7 KB)
  • 45 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model
Markus Scholz, Manuela Ackermann, Frank Emmrich, Markus Loeffler & Manja Kamprad
Pages: 27-37
Published online: 07 Dec 2022
AbstractforEffectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model | Full Text | References | PDF (844.9 KB)
  • 95 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?
Martina Koch, Thomas Becker, Rainer Lueck, Michael Neipp, Juergen Klempnauer & Bjoern Nashan
Pages: 51-56
Published online: 07 Dec 2022
AbstractforBasiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years? | Full Text | References | PDF (102.7 KB)
  • 100 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia
Eric Cheung & Howard A Liebman
Pages: 57-62
Published online: 07 Dec 2022
AbstractforAnti-RhD immunoglobulin in the treatment of immune thrombocytopenia | Full Text | References | PDF (76.3 KB)
  • 72 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
Caitriona McLean, Catherine M Greene & Noel G McElvaney
Pages: 63-75
Published online: 07 Dec 2022
AbstractforGene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency | Full Text | References | PDF (227.6 KB)
  • 88 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Biologic targeting in the treatment of inflammatory bowel diseases
Matteo Bosani, Sandro Ardizzone & Gabriele Bianchi Porro
Pages: 77-97
Published online: 07 Dec 2022
AbstractforBiologic targeting in the treatment of inflammatory bowel diseases | Full Text | References | PDF (239.8 KB)
  • 130 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Front line treatment of elderly multiple myeloma in the era of novel agents
Marie-Dominique Venon, Aldo M Roccaro, Julie Gay, Anne-Sophie Moreau, Remy Dulery, Thierry Facon, Irene M Ghobrial & Xavier Leleu
Pages: 99-109
Published online: 07 Dec 2022
AbstractforFront line treatment of elderly multiple myeloma in the era of novel agents | Full Text | References | PDF (107.6 KB)
  • 69 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Palifermin for management of treatment-induced oral mucositis in cancer patients
Andrei Barasch, Joel Epstein & Ken Tilashalski
Pages: 111-116
Published online: 07 Dec 2022
AbstractforPalifermin for management of treatment-induced oral mucositis in cancer patients | Full Text | References | PDF (73.6 KB)
  • 96 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A
Steven Pipe
Pages: 117-125
Published online: 07 Dec 2022
AbstractforAntihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A | Full Text | References | PDF (98.2 KB)
  • 66 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Challenges in the management of juvenile idiopathic arthritis with etanercept
Clare E Pain & Liza J McCann
Pages: 127-139
Published online: 07 Dec 2022
AbstractforChallenges in the management of juvenile idiopathic arthritis with etanercept | Full Text | References | PDF (123.9 KB)
  • 79 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Management of chronic hepatitis C treatment failures: role of consensus interferon
Stevan A Gonzalez & Emmet B Keeffe
Pages: 141-150
Published online: 07 Dec 2022
AbstractforManagement of chronic hepatitis C treatment failures: role of consensus interferon | Full Text | References | PDF (190.9 KB)
  • 51 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
Lawrence Rice
Pages: 151-157
Published online: 07 Dec 2022
AbstractforTreatment of immune thrombocytopenic purpura: focus on eltrombopag | Full Text | References | PDF (81.4 KB)
  • 90 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Ustekinumab in the therapy of chronic plaque psoriasis
Jenna L O’Neill & Robert E Kalb
Pages: 159-168
Published online: 07 Dec 2022
AbstractforUstekinumab in the therapy of chronic plaque psoriasis | Full Text | References | PDF (216 KB)
  • 79 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Long-term pegylated interferon-α and its potential in the treatment of melanoma
Reinhard Dummer & Joanna Mangana
Pages: 169-182
Published online: 07 Dec 2022
AbstractforLong-term pegylated interferon-α and its potential in the treatment of melanoma | Full Text | References | PDF (940.6 KB)
  • 65 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Infliximab in the treatment of rheumatoid arthritis
A Perdriger
Pages: 183-191
Published online: 07 Dec 2022
AbstractforInfliximab in the treatment of rheumatoid arthritis | Full Text | References | PDF (181.7 KB)
  • 188 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
Radhakrishnan Ramchandren & Charles A Schiffer
Pages: 205-214
Published online: 07 Dec 2022
AbstractforDasatinib in the treatment of imatinib refractory chronic myeloid leukemia | Full Text | References | PDF (95.7 KB)
  • 67 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
Chad A Reade & Apar Kishor Ganti
Pages: 215-224
Published online: 07 Dec 2022
AbstractforEGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab | Full Text | References | PDF (261.3 KB)
  • 134 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
Joseph M Tuscano & Jacob Sands
Pages: 225-232
Published online: 07 Dec 2022
AbstractforB cell reductive therapy with rituximab in the treatment of rheumatoid arthritis | Full Text | References | PDF (158 KB)
  • 51 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Potentials and limitations of microorganisms as renal failure biotherapeutics
Poonam Jain, Sapna Shah, Razek Coussa & Satya Prakash
Pages: 233-243
Published online: 07 Dec 2022
AbstractforPotentials and limitations of microorganisms as renal failure biotherapeutics | Full Text | References | PDF (188.6 KB)
  • 85 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells
Arvind Kumar, Tryambak D Singh, Santosh K Singh & Satya Prakash
Pages: 245-256
Published online: 07 Dec 2022
AbstractforMethods, potentials, and limitations of gene delivery to regenerate central nervous system cells | Full Text | References | PDF (178.5 KB)
  • 53 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Early stage and long term treatment of multiple sclerosis with interferon-β
Angela Applebee & Hillel Panitch
Pages: 257-271
Published online: 07 Dec 2022
AbstractforEarly stage and long term treatment of multiple sclerosis with interferon-β | Full Text | References | PDF (228 KB)
  • 50 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
The old and new therapeutic approaches to the treatment of giardiasis: Where are we?
Haendel GNO Busatti, Joseph FG Santos & Maria A Gomes
Pages: 273-287
Published online: 07 Dec 2022
AbstractforThe old and new therapeutic approaches to the treatment of giardiasis: Where are we? | Full Text | References | PDF (232.6 KB)
  • 282 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Review Article
HER2 breast cancer therapies: a review
Conleth G Murphy & Shanu Modi
Pages: 289-301
Published online: 07 Dec 2022
AbstractforHER2 breast cancer therapies: a review | Full Text | References | PDF (270.3 KB)
  • 412 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature
Jochen Schmitt & Gottfried Wozel
Pages: 303-318
Published online: 07 Dec 2022
AbstractforTargeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature | Full Text | References | PDF (229.6 KB)
  • 90 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
Junichiro Sageshima, Gaetano Ciancio, Linda Chen & George W Burke III
Pages: 319-336
Published online: 07 Dec 2022
AbstractforAnti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation | Full Text | References | PDF (259.4 KB)
  • 61 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review
Bernd Th Krause, Ralf Ohlinger & Annette Haase
Pages: 337-347
Published online: 07 Dec 2022
AbstractforLutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review | Full Text | References | PDF (183.4 KB)
  • 71 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)
Claire Booth & H Bobby Gaspar
Pages: 349-358
Published online: 07 Dec 2022
AbstractforPegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID) | Full Text | References | PDF (174 KB)
  • 323 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Review Article
First-line treatment of acute lymphoblastic leukemia with pegasparaginase
Riccardo Masetti & Andrea Pession
Pages: 359-368
Published online: 07 Dec 2022
AbstractforFirst-line treatment of acute lymphoblastic leukemia with pegasparaginase | Full Text | References | PDF (200.3 KB)
  • 126 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
Damiano Paolicelli, Vita Direnzo & Maria Trojano
Pages: 369-376
Published online: 07 Dec 2022
AbstractforReview of interferon beta-1b in the treatment of early and relapsing multiple sclerosis | Full Text | References | PDF (180.5 KB)
  • 87 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Finding a new drug and vaccine for emerging swine flu: What is the concept?
Viroj Wiwanitkit
Pages: 377-383
Published online: 07 Dec 2022
AbstractforFinding a new drug and vaccine for emerging swine flu: What is the concept? | Full Text | References | PDF (160.4 KB)
  • 67 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma
Francesca Cainelli & Alfredo Vallone
Pages: 385-390
Published online: 07 Dec 2022
AbstractforSafety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma | Full Text | References | PDF (138.1 KB)
  • 87 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies
Laith Altaweel, Daniel Sweeney, Xizhong Cui, Amisha Barochia, Charles Natanson & Peter Q Eichacker
Pages: 391-406
Published online: 07 Dec 2022
AbstractforGrowing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies | Full Text | References | PDF (439 KB)
  • 50 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Review of the safety and efficacy of imiglucerase treatment of Gaucher disease
Deborah Elstein & Ari Zimran
Pages: 407-417
Published online: 07 Dec 2022
AbstractforReview of the safety and efficacy of imiglucerase treatment of Gaucher disease | Full Text | References | PDF (191.3 KB)
  • 181 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
Bryan A Faller & Barbara Burtness
Pages: 419-428
Published online: 07 Dec 2022
AbstractforTreatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy | Full Text | References | PDF (183.4 KB)
  • 144 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
Jia Li & Muhammad Wasif Saif
Pages: 429-441
Published online: 07 Dec 2022
AbstractforCurrent use and potential role of bevacizumab in the treatment of gastrointestinal cancers | Full Text | References | PDF (264.9 KB)
  • 75 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs
Manil Kukar, Olga Petryna & Petros Efthimiou
Pages: 443-457
Published online: 07 Dec 2022
AbstractforBiological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs | Full Text | References | PDF (438.1 KB)
  • 105 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase
Regina P El Dib & Gregory M Pastores
Pages: 459-468
Published online: 07 Dec 2022
AbstractforA systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase | Full Text | References | PDF (352.9 KB)
  • 67 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments
Gesmar RS Segundo, Fabíola A Gomes, Karla P Fernandes, Ronaldo Alves, Deise AO Silva & Ernesto A Taketomi
Pages: 469-474
Published online: 07 Dec 2022
AbstractforLocal cytokines and clinical symptoms in children with allergic rhinitis after different treatments | Full Text | References | PDF (254.7 KB)
  • 79 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Targeted therapy in melanoma
Hussein Tawbi & Neelima Nimmagadda
Pages: 475-484
Published online: 07 Dec 2022
AbstractforTargeted therapy in melanoma | Full Text | References | PDF (173.3 KB)
  • 80 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project
Kylie Thaler, Divya V Chandiramani, Richard A Hansen & Gerald Gartlehner
Pages: 485-498
Published online: 07 Dec 2022
AbstractforEfficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project | Full Text | References | PDF (288.8 KB)
  • 92 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Review Article
New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
Ara Metjian & Charles S Abrams
Pages: 499-513
Published online: 07 Dec 2022
AbstractforNew advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents | Full Text | References | PDF (260.8 KB)
  • 52 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Explore articles